Richard Marshak - Nov 14, 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
SR.VP, CORP. DEV. & STRATEGY
Signature
/s/ Sean Murphy, Attorney-in-Fact
Stock symbol
TLSI
Transactions as of
Nov 14, 2024
Transactions value $
$0
Form type
4
Date filed
11/15/2024, 07:00 PM
Previous filing
Feb 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +6.88K +25.23% $0.00 34.1K Nov 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +41.3K $0.00 41.3K Nov 14, 2024 Common Stock 41.3K $4.01 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 14, 2024, subject to the Reporting Person's continuous service with the Issuer on each such date.
F2 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 14, 2024, and 1/36th of the remaining shares shall vest each month thereafter, subject to the Reporting Person's continuous service with the Issuer through each such vesting date.